F.A.Q.
Sign in
0 Product Products (empty)

No products

€0.00 Total

Check out

Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products
Continue shopping Proceed to checkout
Sciva International s.r.o.
Menu
  • Home
  • E-SHOP
    • CBD oils
    • Capsules
      • Veterinary products
      • Wellness products
      • Cosmetic products
    • About us
    • RESEARCH DATA
      • ANXIETY
      • ALZHEIMER´S
      • ADDICTION
      • ADD/ADHD
      • AIDS
      • ALS
      • ANOREXIA
      • ANTIBIOTIC RESISTANCE
      • ARTHRITIS
      • ATHEROSCLEROSIS
      • ASTHMA
      • AUTISM
      • BIPOLAR
      • CANCER STUDIES
      • CHRONS AND STOMACH PROBLEMS
      • DEPRESSION
      • DIABETES
      • ENDOCRINE DISORDERS
      • EPILEPSY/SEIZURE
      • FIBRYOMALGI
      • GLAUCOMA
      • HEART DISEASE
      • HUNTINGTON´S
      • INFLAMATIONS
      • IRRITABLE BOWEL SYNDROM
      • KIDNEY DISEASE
      • LIVER DISEASE
      • METABOLIC SYNDROME
      • MIGRAINE
      • MOOD DISORDERS
      • MOTION SICKNESS
      • MS/MULTIPLE SCLEROSIS
      • NAUSEA
      • NEURODEGENERATION
      • NEUROPATHIC PAIN
      • OBESITY
      • OCD
      • OSTEOPOROSIS
      • PARKINSON DISEASE
      • PRION/MAD COW DISEASE
      • PTSD
      • RHEUMATISM
      • SCHIZOPHRENIA
      • SICKLE CELL ANEMIA
      • SKIN CODITION
      • SLEEP DISORDERS
      • SPINAL CORD INJURY
      • STRESS
      • STROKE/TBI
    • Blog
    • Testimonials
    • Contact
    / RESEARCH DATA/ CHRONS AND STOMACH PROBLEMS

    Cannabidiol in inflammatory bowel diseases: a brief overview (PubMed)

    Cannabis finds its way into treatment of Crohn’s disease (PubMed)

    Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (PubMed)

    Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis (PubMed)

    The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (PubMed)

    Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice (PubMed)

    Cannabinoids and the gut: New developments and emerging concepts (PubMed)

    Endocannabinoids and the gastrointestinal tract (PubMed)

    Cannabinoids and gastrointestinal motility: Animal and human studies (PubMed)

    Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis (O’Shaughnessy’s)


    Stay connected

    • Facebook
    • Youtube
    • Instagram

    Our website processes cookies in order to increase the user-friendliness of the website and, in the case of your consent, to personalize ads. More info

    close

    Disclaimer

    This website is an initiative of the company Sciva International s.r.o., which has its head office in Prague, the Czech Republic.

    Sciva International s.r.o. shall not be held liable for the medical claims made by customers. It should be noted that these products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care professionals. Sciva International s.r.o. does not make any health claims about our products except those officially approved by EFSA and recommends consulting with health care professionals prior to consuming our products. It is especially important for those who are pregnant, nursing, chronically ill, elderly to discuss the use of these products with health care professionals. You must be 18 years or older to visit this website and/or purchase the products. The website may contain references in the form of hyperlinks, banners or buttons for example, to third party websites. Sciva International s.r.o. has no authority over these websites. The rights relating to this website, including those of intellectual ownership, copyright on text, streaming videos, images, design, data files, photographs and other (moving or stationary) visual material, audio material, formats, software, brands (including domain names) and other material are held by Sciva International s.r.o. and/or its licensing body.

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.



    Cookies Consent to processing of personal data

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.

    Are you more than
    18 years of age?

    Yes No